Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 Mg/ml Concentrate For Solution For Infusion, El(26)a/14

Recalling firm
Baxter Healthcare Corporation
Reason
Baxter Healthcare Corporation have informed the MHRA that the Patient Information Leaflet (PIL) packed in specified batches does not contain up to date information relating to the duration of contraception required for females after stopping taking this medication.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2026-03-17
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/0210d580-9e3d-4b1d-8205-4657ee3a6203